Data Availability
Data to support the findings in the study are available from the corresponding author upon request.
Posted May 17, 2022.
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the Omicron wave
